Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Cabanillas

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
British Journal of Haematology|July 22, 2014
Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphomaMichael Craig, Wahid T Hanna, Fernando Cabanillas, et al.
Puerto Rico Health Sciences Journal|August 31, 2010
Clinicopathological factors associated to HER-2 status in a hospital-based sample of breast cancer patients in Puerto RicoAna P Ortiz, Orquídea Frías, Carmen González-Keelan, et al.
Cancer Journal (Sudbury, Mass.)|September 12, 2003
Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphomaBouthaina S Dabaja, Chul S Ha, Richard B Wilder, et al.
American Journal of Clinical Pathology|September 11, 2002
Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sectionsGeorge Z Rassidakis, Dan Jones, Athanasios Thomaides, et al.
Anticancer Research|April 22, 2011
Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancerDavid R Fogelman, Robert A Wolff, Scott Kopetz, et al.
Cancer Journal (Sudbury, Mass.)|March 6, 2004
Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21)Chul S Ha, Ming-Sheng Lee, Peter McLaughlin, et al.
Leukemia & Lymphoma|October 27, 2006
Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphomaBarbara Pro, Fredrick B Hagemeister, Peter McLaughlin, et al.
Cancer|February 22, 2002
Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphomaRichard B Wilder, Jorge E Romaguera, Susan L Tucker, et al.
Leukemia & Lymphoma|October 29, 2002
Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphomaApostolia-Maria Tsimberidou, Yunfang Jiang, Richard J Ford, et al.
Puerto Rico Health Sciences Journal|July 13, 2012
Triple negative breast cancer: a retrospective study of Hispanics residing in Puerto RicoMaria Y Giraldo-Jiménez, Fernando Cabanillas, Viviana Negrón, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
British Journal of Haematology|July 22, 2014
Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphomaMichael Craig, Wahid T Hanna, Fernando Cabanillas, et al.
Puerto Rico Health Sciences Journal|August 31, 2010
Clinicopathological factors associated to HER-2 status in a hospital-based sample of breast cancer patients in Puerto RicoAna P Ortiz, Orquídea Frías, Carmen González-Keelan, et al.
Cancer Journal (Sudbury, Mass.)|September 12, 2003
Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphomaBouthaina S Dabaja, Chul S Ha, Richard B Wilder, et al.
American Journal of Clinical Pathology|September 11, 2002
Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sectionsGeorge Z Rassidakis, Dan Jones, Athanasios Thomaides, et al.
Anticancer Research|April 22, 2011
Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancerDavid R Fogelman, Robert A Wolff, Scott Kopetz, et al.
Cancer Journal (Sudbury, Mass.)|March 6, 2004
Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21)Chul S Ha, Ming-Sheng Lee, Peter McLaughlin, et al.
Leukemia & Lymphoma|October 27, 2006
Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphomaBarbara Pro, Fredrick B Hagemeister, Peter McLaughlin, et al.
Cancer|February 22, 2002
Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphomaRichard B Wilder, Jorge E Romaguera, Susan L Tucker, et al.
Leukemia & Lymphoma|October 29, 2002
Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphomaApostolia-Maria Tsimberidou, Yunfang Jiang, Richard J Ford, et al.
Puerto Rico Health Sciences Journal|July 13, 2012
Triple negative breast cancer: a retrospective study of Hispanics residing in Puerto RicoMaria Y Giraldo-Jiménez, Fernando Cabanillas, Viviana Negrón, et al.
Pageof 11